Skip to main content
OpenTrials

Clinical trial condition

T-cell Lymphoma

Explore clinical trials studying T-cell Lymphoma. Study availability and eligibility vary by location and protocol.

34 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

T-cell Lymphoma trial results

Completed

ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas

NCT01777152

Conditions
Anaplastic Large-Cell Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Shands Cancer Center / University of Florida Gainesville, Florida, United States
View all 144 locations
View Trial Details
Completed

Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)

NCT01553786

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Université Catholique de Louvain Saint Luc Brussels, Belgium
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Université Catholique de Louvain Mont Godinne Yvoir, Belgium
  • CHU d'Amiens - Hôpital Sud Amiens, France
View all 30 locations
View Trial Details
Completed

A Study for Patients With Non-Hodgkin's Lymphomas

NCT00542919

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Anaheim, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Garran, Australian Capital Territory, Australia
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gosford, New South Wales, Australia
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Auchenflower, Queensland, Australia
View all 14 locations
View Trial Details
Completed

Tandem Auto-Allo Transplant for Lymphoma

NCT01181271

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse, Large B-Cell, Lymphoma, +27 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies

NCT01871675

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
Locations
  • The Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Oklahoma University Oklahoma City, Oklahoma, United States
  • Tennessee Oncology, PLLC Nashville, Tennessee, United States
View Trial Details

Related conditions